Kreaxi
  • Our DNA
  • Team
  • Portfolio
  • Impact
  • News
  • Contact
  • Français
Select Page

Theranexus to present the results of THN102 for Parkinson’s disease at the 2020 International Congress of Parkinson’s Disease and Movement disorders

Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells, will present the Phase II results of its drug candidate THN102...

Amoéba: the efficacy of the biocontrol solution against grapevine downy mildew confirmed through the second European field trials campaign

AMOEBA (FR0011051598 – AMEBA), – producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, announces that the results of the second field trials...

Field tests confirm the efficacy of Amoeba’s biocontrol solution on several major wheat diseases

AMOEBA (FR0011051598 – AMEBA) – producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, announces the first efficacy results of its biocontrol...

Recent Posts

  • Gustave Roussy and LXRepair announce a partnership for personalized radiotherapy of cancer
  • Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners
  • Amolyt Pharma to Host Key Opinion Leader Webinar and Discuss Results of Phase I Clinical Trial of AZP-3601 on Friday, October 1st at 10:00am ET
  • Amolyt Pharma Exercises Option to License Optimized Acromegaly Drug Candidate from PeptiDream as it Continues to Build its Rare Endocrine Pipeline.
  • Theranexus and Beyond Batten Disease Foundation (BBDF) win us Investigational New Drug (IND) approval to start clinical development of BBDF 101

Archives

  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • April 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • March 2019
  • February 2019
  • December 2018
  • November 2018
  • December 2017
  • September 2017
  • April 2017

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

About us

Kreaxi is an investment management firm specialized in the equity financing of innovative, deeptech & lowtech startups with high growth potential. Kreaxi manages regional funds in France, focusing on Auvergne-Rhône-Alpes region as well as French and pan-european funds.

Lyon

101, Chemin Vert
69760 Limonest 
France

+33 4 72 52 39 39

Paris

13-15 rue Taitbout
75009 Paris
France

+33 1 73 02 89 69

  • Twitter
© 2022 Kreaxi. Tous droits réservés. Mentions légales. Informations réglementaires.
Nous utilisons des cookies sur notre site web pour vous offrir l'expérience la plus adaptée en nous souvenant de vos préférences lors de vos prochaines visites. En cliquant sur “Tout accepter”, vous consentez à l'usage de l'ensemble des cookies. Cependant, vous pouvez visiter "Paramétrage" pour détailler votre consentement.
ParamétrageTout accepter
Manager votre consentement

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
SAVE & ACCEPT